Skip to main content
Clinical Trials/NL-OMON40298
NL-OMON40298CompletedNot Applicable

Study of the cerebral effects of sevoflurane, propofol and remifentanil as measured by the spontaneous electro-encephalogram - Improving the measurement of cerebral anesthetic drug effects

MASIMO0 sites36 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
MASIMO
Enrollment
36

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Healthy volunteers aged 18 to 70 years.
  • 18-35 y 6 men / 6 women
  • 35-50 y 6 men / 6 women
  • 50-70 y 6 men / 6 women

Exclusion Criteria

  • Volunteer refusal
  • - Volunteer < 18 years and >70 years
  • - Exclusion criteria are weight less than 70% or more than 130% of ideal body weight
  • - Neurological disorder
  • - Diseases involving the cardiovascular system (hypertension, coronary artery disease, prior acute myocardial infarction, any valvular and/or myocardial disease involving decrease in ejection fraction, arrhythmias, which are either symptomatic or require continuous medication/pacemaker/automatic internal cardioverter defibrillator)
  • - Pulmonary diseases
  • - Gastric diseases
  • - Endocrinologic diseases
  • - Recent use of psycho-active medication or more than 20 g of alcohol daily.
  • -Drug abuse

Investigators

Sponsor
MASIMO

Similar Trials

Study of the cerebral effects of... | Clinical Trial